糖尿病抑郁共病治疗管理研究进展 |
投稿时间:2018-01-24 修订日期:2018-05-11 点此下载全文 |
引用本文:任宇,方铭,俞俊,徐峰.糖尿病抑郁共病治疗管理研究进展[J].药学实践杂志,2018,36(4):297~300 |
摘要点击次数: 1297 |
全文下载次数: 2500 |
|
基金项目:上海临床药学创新研究项目(2016-YY-01-16);上海医院药学科研项目(2017-YY-02-17) |
|
中文摘要:糖尿病患者有较高的抑郁症患病风险,可对患者的主观幸福感和生活质量产生不利影响,并可能增加降糖治疗不顺从性。糖尿病患者的抑郁可通过心理治疗及药物方式得到有效缓解,及时有效地治疗抑郁症可以显著提高糖尿病患者的生活质量,减轻患者的心理负担,促进降糖治疗的有效开展。针对糖尿病抑郁共病的相关危险因素、共病诊断、慢性病治疗管理等方面的研究进展作一综述。 |
中文关键词:糖尿病 抑郁 共病 治疗管理 |
|
Recent progress in chronic disease medication therapy management: diabetes comorbidity with depression |
|
|
Abstract:Patients with diabetes have higher risks of depression that may adversely affect subjective well-being and quality of life, and may increase the non-compliance of glycemic control. Depression in diabetic patients can be effectively relieved by psychotherapy and medication therapy, which can significantly improve the quality of life for diabetic patients, alleviate the psychological burden of patients and promote the effective development of glycemic control. This article reviews the research progress in the hazards, comorbidity identification and managements related to depression with diabetes mellitus. |
keywords:diabetes depression comorbidity medication therapy management |
查看全文 查看/发表评论 下载PDF阅读器 |
|
关闭 |